Laboratorios Farmaceuticos Rovi
ROVI.MC
#3547
Rank
NZ$5.08 B
Marketcap
$99.48
Share price
0.10%
Change (1 day)
-28.32%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2024 (TTM): NZ$0.37 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are NZ$0.87 Billion. In 2023 the company made an earning of NZ$0.42 Billion a decrease over its 2022 earnings that were of NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.37 B-10.68%
2023 NZ$0.42 B-12.68%
2022 NZ$0.48 B29.26%
2021 NZ$0.37 B149.39%
2020 NZ$0.14 B79.65%
2019 NZ$83.16 M128.8%
2018 NZ$36.34 M0.15%
2017 NZ$36.29 M-35.28%
2016 NZ$56.07 M27.59%
2015 NZ$43.95 M-32.06%
2014 NZ$64.69 M8.39%
2013 NZ$59.68 M-4.32%
2012 NZ$62.38 M2.78%
2011 NZ$60.69 M-2.15%
2010 NZ$62.03 M